首页|HBP、SAA、nCD64在颅内感染早期诊疗中作用的研究进展

HBP、SAA、nCD64在颅内感染早期诊疗中作用的研究进展

扫码查看
开颅术后颅内感染是神经外科的严重并发症,其致残、致死率均较高。临床常规检测颅内感染指标的特异性、敏感性不足,脑脊液细菌培养耗时且阳性率低。近年来,肝素结合蛋白(HBP)、血清淀粉样蛋白A(SAA)、中性粒细胞CD64(nCD64)作为新型感染标志物,在敏感性、特异性方面具有独特优势,并且检测方法简便快捷,在感染诊断、疗效评估、预后判断等方面具有广泛的临床应用前景。本文从HBP、SAA、nCD64在颅内感染早期中的诊断价值、临床应用及检测方法等方面进行综述。
Research progress on the role of HBP,SAA,and nCD64 in the early diagnosis and treatment of intracranial infection
Post-craniotomy intracranial infection is a serious complication in neurosurgery,with high rates of disability and mor-tality.The specificity and sensitivity of routine clinical detection of intracranial infection indicators were insufficient,and cerebrospi-nal fluid bacterial culture was time-consuming and had a low positive rate.In recent years,heparin binding protein(HBP),serum amyloid A(SAA),and neutrophil CD64 have unique advantages in sensitivity and specificity as novel infection markers,and their de-tection methods were simple and fast.They have broad clinical application prospects in infection diagnosis,efficacy evaluation,prog-nosis judgment,and other aspects.This article reviews the diagnostic value,clinical application,and detection methods of HBP,SAA,and nCD64 in the early stage of intracranial infection.

HBPSAAnCD64intracranial infectionearly diagnosis and treatment

赵亚宁、胡涛、王一鸣、任子阳、陈胜利

展开 >

山西医科大学第五临床医学院神经外科,山西太原 030012

肝素结合蛋白 血清淀粉样蛋白A 中性粒细胞CD64 颅内感染 早期诊疗

山西省医学重点科研项目山西省基础研究计划项目

2023XM030202203021211057

2024

中南医学科学杂志
南华大学

中南医学科学杂志

CSTPCD
影响因子:0.757
ISSN:2095-1116
年,卷(期):2024.52(4)
  • 15